XVIVO Achieves Significant Milestone in Italy: Liver Assist Enables 1,200 Lifesaving Perfusions
XVIVO, a leading medical technology company specializing in organ preservation and perfusion solutions, has achieved a significant milestone in Italy. The company’s Liver Assist system has enabled 1,200 lifesaving perfusions, marking a major breakthrough in the field of liver transplantation.
Liver transplantation is a complex procedure that involves replacing a diseased or damaged liver with a healthy one from a donor. However, the success of this procedure heavily relies on the quality and viability of the donor organ. XVIVO’s Liver Assist system plays a crucial role in preserving and assessing the quality of donor livers before transplantation.
The Liver Assist system utilizes a unique perfusion technique called normothermic machine perfusion (NMP). NMP involves pumping oxygenated blood and nutrients through the liver at body temperature, mimicking the conditions inside the human body. This process helps to maintain the organ’s function and vitality during transportation and evaluation.
One of the key advantages of XVIVO’s Liver Assist system is its ability to assess the viability of donor livers in real-time. The system continuously monitors various parameters such as oxygen consumption, bile production, and vascular resistance, providing valuable insights into the organ’s health and suitability for transplantation. This real-time assessment allows surgeons to make informed decisions about whether to proceed with the transplantation or not, ultimately improving patient outcomes.
The achievement of 1,200 lifesaving perfusions in Italy is a testament to the effectiveness and reliability of XVIVO’s Liver Assist system. The system has been instrumental in increasing the number of viable donor livers available for transplantation, thereby reducing waiting times for patients in need.
Dr. Giovanni Vennarecci, a renowned transplant surgeon at the University Hospital Tor Vergata in Rome, Italy, expressed his enthusiasm about XVIVO’s Liver Assist system. He stated, “The Liver Assist system has revolutionized the way we evaluate and preserve donor livers. It has significantly improved our ability to assess the quality of organs and has allowed us to successfully transplant livers that would have been deemed unsuitable in the past.”
The success of XVIVO’s Liver Assist system in Italy has not only benefited patients but also healthcare systems. By increasing the number of viable donor livers, the system has helped reduce healthcare costs associated with prolonged hospital stays and complications arising from unsuccessful transplantations.
XVIVO’s achievement in Italy is a significant milestone in the field of liver transplantation. The Liver Assist system has proven to be a game-changer, enabling more successful transplantations and saving countless lives. With ongoing advancements in organ preservation and perfusion technologies, the future looks promising for patients awaiting liver transplants.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: Plato Data Intelligence.
- Source Link: https://platohealth.ai/xvivo-reaches-milestone-in-italy-1200-lifesaving-perfusions-performed-with-liver-assist-biospace/
An Overview of the FDA’s Draft Guidance on Translation of GLP Study Reports in the United States
An Overview of the FDA’s Draft Guidance on Translation of GLP Study Reports in the United States The Food and...